UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 254

Sortiert nach

CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer

Molecular cancer therapeutics, 2015-11, Vol.14 (11), p.2473-2485

2015

Volltextzugriff (PDF)

Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti–Vascular Endothelial Growth Factor Therapy–Induced Glioma Dissemination

The American journal of pathology, 2017-09, Vol.187 (9), p.2080-2094

2017

Volltextzugriff (PDF)

The translational challenge in the development of new and effective therapies for endometriosis: a review of confidence from published preclinical efficacy studies

Human reproduction update, 2011-11, Vol.17 (6), p.791-802

2011

Volltextzugriff (PDF)

Protective effect of a Protein Epitope Mimetic CCR10 antagonist, POL7085, in a model of allergic eosinophilic airway inflammation

Respiratory research, 2015-06, Vol.16 (1), p.77-77, Article 77

2015

Volltextzugriff (PDF)

Post-Paramyxoviral Mucous Cell Metaplasia Is CCL28 and CCR10 Dependent

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB145-AB145

2015

Volltextzugriff (PDF)

POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL

Oncotarget, 2015-10, Vol.6 (31), p.30902-30918

2015

Volltextzugriff (PDF)

POL7085 or anti‐CCL28 treatment inhibits development of post‐paramyxoviral airway disease

Immunity, Inflammation and Disease, 2017-06, Vol.5 (2), p.98-108

2017

Volltextzugriff (PDF)

Anti-inflammatory modulation of chronic airway inflammation in the murine house dust mite model

Pulmonary pharmacology & therapeutics, 2008-08, Vol.21 (4), p.637-647

2008

Volltextzugriff (PDF)

Abstract 3965: Circulating levels of IFN gammaand neutrophil counts in breast cancer patients who received balixafortide and eribulin combination therapy

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3965-3965

2019

Volltextzugriff (PDF)

Pharmacology, ADME and selectivity profile of the next generation CXCR4 antagonist balixafortide

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e14553-e14553

2018

Volltextzugriff (PDF)

Formyl Peptide Receptor-1 Blockade Prevents Receptor Regulation by Mitochondrial Danger-Associated Molecular Patterns and Preserves Neutrophil Function After Trauma

Critical care medicine, 2020-02, Vol.48 (2), p.e123

2020

Volltextzugriff (PDF)

Direct Airway Instillation of Neutrophils Overcomes Chemotactic Deficits Induced by Injury

Shock (Augusta, Ga.), 2021-07, Vol.56 (1), p.119-124

2021

Volltextzugriff (PDF)

Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial

Journal of translational medicine, 2017-01, Vol.15 (1), p.2, Article 2

2017

Volltextzugriff (PDF)

POL5551, a Novel and Potent CXCR4 Antagonist, Enhances Sensitivity to Chemotherapy in an in Vivo Model of High-Risk (HR) Pediatric Acute Lymphoblastic Leukemia (ALL)

Blood, 2014-12, Vol.124 (21), p.3707-3707

2014

Volltextzugriff (PDF)

Potent Stem Cell Mobilization with the Novel CXCR4 Antagonist POL6326 - Results of a Phase IIa Dose Escalation Study in Comparison to G-CSF

Blood, 2015-12, Vol.126 (23), p.511-511

2015

Volltextzugriff (PDF)

Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma

Oncotarget, 2014-10, Vol.5 (20), p.9811-9822

2014

Volltextzugriff (PDF)

Abstract A20: A novel CXCR4 antagonist interferes with antivascular endothelial growth factor therapy-induced glioma dissemination

Cancer research (Chicago, Ill.), 2015-12, Vol.75 (23_Supplement), p.A20-A20

2015

Volltextzugriff (PDF)

Abstract 1114: Combination of a novel CXCR4 antagonist with chemotherapy reduces breast cancer bone metastatic tumor burden

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1114-1114

2014

Volltextzugriff (PDF)

Platelet accumulation induced by bacterial endotoxin in rats

Thrombosis research, 1996-09, Vol.83 (6), p.405-419

1996

Volltextzugriff (PDF)

ET-51COMBINED THERAPY WITH A NOVEL CXCR4 ANTAGONIST AND AN ANTI-VEGF ANTIBODY IMPAIRS THE GROWTH OF GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v90-v90

2014

Volltextzugriff (PDF)

POL7085 or anti-CCL28 treatment inhibits development of post-paramyxoviral airway disease: POL7085 inhibits post-viral lung disease

Immunity, Inflammation and Disease, 2017-06, Vol.5 (2), p.98-108

2017

Volltextzugriff (PDF)

ET-51 COMBINED THERAPY WITH A NOVEL CXCR4 ANTAGONIST AND AN ANTI-VEGF ANTIBODY IMPAIRS THE GROWTH OF GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v90-v90

2014

Volltextzugriff (PDF)

An Analysis of Community College Career and Technical Education Course and Completion Rate

Tomerlin, Garry Douglas

2012

Volltextzugriff (PDF)

A study on rat platelet responsiveness following intravenous endotoxin administration

Life sciences (1973), 1997, Vol.60 (2), p.PL31-PL38

1997

Volltextzugriff (PDF)

A novel animal model for investigating persistent airway hyperresponsiveness

Journal of pharmacological and toxicological methods, 1993-12, Vol.30 (4), p.177-188

1993

Volltextzugriff (PDF)

1 – 25 von 254

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(228)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(148)
Life Sciences & Biomedicine
(126)
Humans
(91)
Animals
(46)
Female
(41)
Male
(40)
Biological And Medical Sciences
(35)
Mice
(28)
Middle Aged
(24)
Adult
(22)
Medical Sciences
(22)
Oncology
(21)
Aged
(19)
Biochemistry & Molecular Biology
(19)
Physical Sciences
(17)
Cell Biology
(15)
Technology
(15)
Endocrinology & Metabolism
(13)
Fundamental And Applied Biological Sciences. Psychology
(13)
Adolescent
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer

Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti–Vascular Endothelial Growth Factor Therapy–Induced Glioma Dissemination

The translational challenge in the development of new and effective therapies for endometriosis: a review of confidence from published preclinical efficacy studies

Protective effect of a Protein Epitope Mimetic CCR10 antagonist, POL7085, in a model of allergic eosinophilic airway inflammation

Post-Paramyxoviral Mucous Cell Metaplasia Is CCL28 and CCR10 Dependent

POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL

POL7085 or anti‐CCL28 treatment inhibits development of post‐paramyxoviral airway disease

Anti-inflammatory modulation of chronic airway inflammation in the murine house dust mite model

Abstract 3965: Circulating levels of IFN gammaand neutrophil counts in breast cancer patients who received balixafortide and eribulin combination therapy

Pharmacology, ADME and selectivity profile of the next generation CXCR4 antagonist balixafortide

Formyl Peptide Receptor-1 Blockade Prevents Receptor Regulation by Mitochondrial Danger-Associated Molecular Patterns and Preserves Neutrophil Function After Trauma

Direct Airway Instillation of Neutrophils Overcomes Chemotactic Deficits Induced by Injury

Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial

POL5551, a Novel and Potent CXCR4 Antagonist, Enhances Sensitivity to Chemotherapy in an in Vivo Model of High-Risk (HR) Pediatric Acute Lymphoblastic Leukemia (ALL)

Potent Stem Cell Mobilization with the Novel CXCR4 Antagonist POL6326 - Results of a Phase IIa Dose Escalation Study in Comparison to G-CSF

Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma

Abstract A20: A novel CXCR4 antagonist interferes with antivascular endothelial growth factor therapy-induced glioma dissemination

Abstract 1114: Combination of a novel CXCR4 antagonist with chemotherapy reduces breast cancer bone metastatic tumor burden

Platelet accumulation induced by bacterial endotoxin in rats

ET-51COMBINED THERAPY WITH A NOVEL CXCR4 ANTAGONIST AND AN ANTI-VEGF ANTIBODY IMPAIRS THE GROWTH OF GLIOMAS

POL7085 or anti-CCL28 treatment inhibits development of post-paramyxoviral airway disease: POL7085 inhibits post-viral lung disease

ET-51 COMBINED THERAPY WITH A NOVEL CXCR4 ANTAGONIST AND AN ANTI-VEGF ANTIBODY IMPAIRS THE GROWTH OF GLIOMAS

An Analysis of Community College Career and Technical Education Course and Completion Rate

A study on rat platelet responsiveness following intravenous endotoxin administration

A novel animal model for investigating persistent airway hyperresponsiveness

Suchergebnisse filtern